Targeting diffuse midline gliomas with innovative T cell immunotherapy
Diffuse midline gliomas (DMG), including diffuse intrinsic pontine gliomas (DIPG), are highly aggressive brain tumors that mainly affect children and currently have no cure. Traditional treatments like chemotherapy and radiation have limited success, leaving an urgent need for new therapies to improve survival rates while minimizing side effects. Chimeric antigen ...